Welcome to LookChem.com Sign In|Join Free

CAS

  • or
6-Fluoro-5-methylindole-2-carboxylic acid is a chemical compound with the molecular formula C10H8FNO2. It is a derivative of indole-2-carboxylic acid, featuring a fluorine atom at the 6th position and a methyl group at the 5th position. 6-fluoro-5-methylindole-2-carboxylic acid is known for its potential applications in the synthesis of various pharmaceuticals and agrochemicals, particularly those involving the indole scaffold. It is an important intermediate in the development of new drugs and can be used in the creation of compounds with specific biological activities. The synthesis of 6-fluoro-5-methylindole-2-carboxylic acid often involves multi-step processes that may include fluorination and methylation reactions, highlighting its role as a key building block in organic chemistry and drug design.

1049685-22-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1049685-22-4 Structure
  • Basic information

    1. Product Name: 6-fluoro-5-methylindole-2-carboxylic acid
    2. Synonyms: 6-fluoro-5-methylindole-2-carboxylic acid;6-FLUORO-5-METHYL-1H-INDOLE-2-CARBOXYLIC ACID
    3. CAS NO:1049685-22-4
    4. Molecular Formula: C10H8FNO2
    5. Molecular Weight: 193.1744232
    6. EINECS: -0
    7. Product Categories: N/A
    8. Mol File: 1049685-22-4.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 6-fluoro-5-methylindole-2-carboxylic acid(CAS DataBase Reference)
    10. NIST Chemistry Reference: 6-fluoro-5-methylindole-2-carboxylic acid(1049685-22-4)
    11. EPA Substance Registry System: 6-fluoro-5-methylindole-2-carboxylic acid(1049685-22-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1049685-22-4(Hazardous Substances Data)

1049685-22-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1049685-22-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,9,6,8 and 5 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1049685-22:
(9*1)+(8*0)+(7*4)+(6*9)+(5*6)+(4*8)+(3*5)+(2*2)+(1*2)=174
174 % 10 = 4
So 1049685-22-4 is a valid CAS Registry Number.

1049685-22-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-fluoro-5-methylindole-2-carboxylic acid

1.2 Other means of identification

Product number -
Other names 6-fluoro-5-methyl-1H-indole-2-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1049685-22-4 SDS

1049685-22-4Relevant articles and documents

Property Focused Structure-Based Optimization of Small Molecule Inhibitors of the Protein-Protein Interaction between Menin and Mixed Lineage Leukemia (MLL)

Borkin, Dmitry,Pollock, Jonathan,Kempinska, Katarzyna,Purohit, Trupta,Li, Xiaoqin,Wen, Bo,Zhao, Ting,Miao, Hongzhi,Shukla, Shirish,He, Miao,Sun, Duxin,Cierpicki, Tomasz,Grembecka, Jolanta

, p. 892 - 913 (2016/02/23)

Development of potent small molecule inhibitors of protein-protein interactions with optimized druglike properties represents a challenging task in lead optimization process. Here, we report synthesis and structure-based optimization of new thienopyrimidine class of compounds, which block the protein-protein interaction between menin and MLL fusion proteins that plays an important role in acute leukemias with MLL translocations. We performed simultaneous optimization of both activity and druglike properties through systematic exploration of substituents introduced to the indole ring of lead compound 1 (MI-136) to identify compounds suitable for in vivo studies in mice. This work resulted in the identification of compound 27 (MI-538), which showed significantly increased activity, selectivity, polarity, and pharmacokinetic profile over 1 and demonstrated a pronounced effect in a mouse model of MLL leukemia. This study, which reports detailed structure-activity and structure-property relationships for the menin-MLL inhibitors, demonstrates challenges in optimizing inhibitors of protein-protein interactions for potential therapeutic applications.

2, 3-SUBSTITUTED INDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS

-

Page/Page column 203, (2009/04/25)

The present invention relates to 2,3-Substituted Indole Derivatives, compositions comprising at least one 2,3-Substituted Indole Derivative, and methods of using the 2,3-Substituted Indole Derivatives for treating or preventing a viral infection or a viru

TETRACYCLIC INDOLE DERIVATIVES AND METHODS OF USE THEREOF

-

Page/Page column 131-132, (2009/04/25)

The present invention relates to Tetracyclic Indole Derivatives, compositions comprising at least one Tetracyclic Indole Derivative, and methods of using the Tetracyclic Indole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.

SUBSTITUTED INDOLE DERIVATIVES AND METHODS OF USE THEREOF

-

Page/Page column 169-170, (2009/04/25)

The present invention relates to Substituted Indole Derivatives, compositions comprising at least one Substituted Indole Derivative, and methods of using these Substituted Indole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.

Syntheses of 4-(indole-3-yl)quinazolines - A new class of epidermal growth factor receptor tyrosine kinase inhibitors

Lueth, Anja,Loewe, Werner

, p. 1478 - 1488 (2008/09/21)

The epidermal growth factor (EGF) family of membrane receptors has been identified as a key element in the complex signaling network that is utilized by various classes of cell-surface receptors. The synthesis and pharmacological results of 4-(indole-3-yl)quinazolines are described. The synthesized compounds are new high potent EGFR-tyrosine kinase inhibitors with excellent cytotoxic properties at different cell lines. Furthermore the 4-(indole-3-yl)quinazolines show some tendencies to inhibit the HER-2 TK, too. Moreover this substance class has remarkable strong fluorescence properties.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1049685-22-4